Aurora Cannabis (TSE:ACB) Price Target Cut to C$14.00

Aurora Cannabis (TSE:ACB) had its target price lowered by equities researchers at Desjardins from C$16.50 to C$14.00 in a research report issued on Friday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Desjardins’ price objective would suggest a potential upside of 77.44% from the stock’s current price.

Shares of TSE ACB traded up C$0.14 during mid-day trading on Friday, reaching C$7.89. 4,048,249 shares of the company were exchanged, compared to its average volume of 9,950,801. The company has a quick ratio of 1.80, a current ratio of 2.37 and a debt-to-equity ratio of 14.55. The stock has a market cap of $7.86 billion and a price-to-earnings ratio of -31.27. Aurora Cannabis has a 1 year low of C$6.21 and a 1 year high of C$16.24. The firm has a 50-day moving average of C$8.04 and a 200 day moving average of C$10.21.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: What are momentum indicators and what do they show?

Analyst Recommendations for Aurora Cannabis (TSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit